Yana Reshetnyak, Ph.D.
Professor | President and CEO, pHLIP, Inc.
Professional Overview
Yana Reshetnyak is a respected professor and innovative leader in the field of biochemistry and molecular biology. As a Professor at the University of Rhode Island and the President and CEO of pHLIP, Inc., she leverages her extensive expertise to drive groundbreaking research and commercialize transformative technologies.
Experience Summary
Current Role
As the President and CEO of pHLIP, Inc. since 2014, Dr. Reshetnyak has been instrumental in the development and commercialization of the company's pioneering pH-Low Insertion Peptide (pHLIP) technology. Under her leadership, pHLIP, Inc. has secured multiple patents, established collaborations with leading academic and industry partners, and advanced the clinical applications of pHLIP for targeted drug delivery and cancer imaging.
In her concurrent role as a Professor at the University of Rhode Island, Dr. Reshetnyak conducts cutting-edge research, teaches graduate-level courses, and mentors the next generation of scientists. Her research focuses on the biophysical mechanisms of membrane protein folding and the design of novel peptide-based systems for biomedical applications.
Career Progression
Prior to her current positions, Dr. Reshetnyak held research scientist roles at the University of Connecticut Health Center and the University of Rhode Island, where she made significant contributions to the understanding of membrane protein structure and function. Her research has been published in numerous peer-reviewed journals and has earned her recognition within the scientific community.
Academic Background
Dr. Reshetnyak holds a Ph.D. in Biophysics from the Institute of Theoretical and Experimental Biophysics in Russia. Her doctoral research centered on the structure and dynamics of membrane proteins, laying the foundation for her subsequent work in this field.
Areas of Expertise
- Biochemistry and molecular biology
- Membrane protein structure and function
- Peptide design and engineering
- Targeted drug delivery and cancer imaging
- Biophysical and structural characterization techniques
- Leadership and management of research organizations
Professional Impact
Under Dr. Reshetnyak's guidance, pHLIP, Inc. has successfully translated the pHLIP technology from the laboratory to the clinic, with several ongoing clinical trials and collaborations exploring its potential for cancer detection and treatment. Her research has also contributed to the fundamental understanding of membrane protein folding and dynamics, advancing the field of structural biology.
Conclusion
With her extensive expertise, innovative mindset, and proven track record of success, Yana Reshetnyak is a highly respected leader in the fields of biochemistry and molecular biology. Through her dual roles as a Professor and the President and CEO of pHLIP, Inc., she continues to drive groundbreaking research, commercialize transformative technologies, and contribute to the advancement of the scientific community.
